BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Boehringer Ingelheim
Dow
Accenture
Medtronic
McKinsey
US Army
Merck
Baxter
US Department of Justice

Generated: January 16, 2018

DrugPatentWatch Database Preview

Paricalcitol - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for paricalcitol and what is the scope of paricalcitol patent protection?

Paricalcitol
is the generic ingredient in two branded drugs marketed by Amneal Pharms, Aurobindo Pharma Ltd, Bionpharma Inc, Dr Reddys Labs Ltd, Eci Pharms Llc, Marksans Pharma, Rising Pharms Inc, Teva Pharms Usa, Abbvie, Accord Hlthcare, Akorn, Amneal Pharms Co, Hikma Pharms, Hospira Inc, Mylan Labs Ltd, and Sandoz Inc, and is included in eighteen NDAs. There are two patents protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Paricalcitol has seventeen patent family members in ten countries and one supplementary protection certificate in one country.

There are ten drug master file entries for paricalcitol. Twenty suppliers are listed for this compound. There is one tentative approval for this compound.
Pharmacology for paricalcitol
Ingredient-typeCholecalciferol
Drug ClassVitamin D3 Analog
Tentative approvals for PARICALCITOL
Applicant Application No. Strength Dosage Form
➤ Subscribe➤ Subscribe2MCG/MLINJECTABLE; INJECTION
➤ Subscribe➤ Subscribe10MCG/MLINJECTABLE; INJECTION
➤ Subscribe➤ Subscribe5MCG/MLINJECTABLE; INJECTION

US Patents and Regulatory Information for paricalcitol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bionpharma Inc PARICALCITOL paricalcitol CAPSULE;ORAL 202539-001 Mar 27, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Marksans Pharma PARICALCITOL paricalcitol CAPSULE;ORAL 204948-001 Oct 7, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Labs Ltd PARICALCITOL paricalcitol SOLUTION;INTRAVENOUS 203897-003 Nov 2, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bionpharma Inc PARICALCITOL paricalcitol CAPSULE;ORAL 202539-003 Mar 27, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Labs Ltd PARICALCITOL paricalcitol SOLUTION;INTRAVENOUS 203897-001 Nov 2, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms Co PARICALCITOL paricalcitol SOLUTION;INTRAVENOUS 206699-001 Mar 9, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Rising Pharms Inc PARICALCITOL paricalcitol CAPSULE;ORAL 202124-002 Jun 24, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol SOLUTION;INTRAVENOUS 020819-003 Feb 1, 2000 AP RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Amneal Pharms PARICALCITOL paricalcitol CAPSULE;ORAL 204327-003 Jan 13, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms Co PARICALCITOL paricalcitol SOLUTION;INTRAVENOUS 206699-002 Mar 9, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for paricalcitol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie ZEMPLAR paricalcitol SOLUTION;INTRAVENOUS 020819-001 Apr 17, 1998 ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol CAPSULE;ORAL 021606-002 May 26, 2005 ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol CAPSULE;ORAL 021606-003 May 26, 2005 ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol CAPSULE;ORAL 021606-001 May 26, 2005 ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol CAPSULE;ORAL 021606-003 May 26, 2005 ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol CAPSULE;ORAL 021606-002 May 26, 2005 ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol SOLUTION;INTRAVENOUS 020819-002 Feb 1, 2000 ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol SOLUTION;INTRAVENOUS 020819-001 Apr 17, 1998 ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol CAPSULE;ORAL 021606-001 May 26, 2005 ➤ Subscribe ➤ Subscribe
Abbvie ZEMPLAR paricalcitol SOLUTION;INTRAVENOUS 020819-002 Feb 1, 2000 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for paricalcitol

Supplementary Protection Certificates for paricalcitol

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB04/003 United Kingdom ➤ Subscribe PRODUCT NAME: PARICALCITOL; REGISTERED: ES SPAIN 64.974 20020809; UK PL 00037/0403 20030721
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Fuji
Express Scripts
UBS
Mallinckrodt
Farmers Insurance
Daiichi Sankyo
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot